On May 12, President Trump signed an executive order directing the administration to communicate most-favored-nation drug price targets to pharmaceutical manufacturers for sales in the United States.
The Association of American Cancer Institutes started a monthly newsletter roundup titled “Defending Cancer Research Digest.”
The House Committee on Energy and Commerce budget reconciliation bill, which includes attacks on Medicaid and Affordable Care Act coverage and fails to extend ACA tax credits, would increase the number of uninsured people by at least 13.7 million.
The Kaiser Family Foundation has released a tracking poll compiling data from the first 100 days of the Trump administration.
Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts
Harvard University filed an amended lawsuit against the Trump administration, seeking to add two more federal agencies as defendants and to address the administration’s widening efforts to cut the university’s federal funding—now targeting over $2.6 billion and all future grants.
Over $180 million in NCI grants have been terminated between Feb. 28 and April 8, according to a systematic review published in JAMA May 8.
In an interview with Science, NIH Director Jay Bhattacharya said that his time at the NIH has been a “tough period”—especially for him.
In a statement issued on May 1, NIH said it’s immediately halting most new grant awards to foreign partners working in US-led research consortia.
On April 21, investigators with the Women’s Health Initiative were notified that HHS planned to terminate the WHI Regional Center contracts at the end of the current fiscal year (The Cancer Letter, April 20, 2025).
The American Association for Cancer Research called on Congress to stand up in unified opposition to President Trump’s FY2026 budget proposal for NIH, and to instead allocate a robust funding increase to $51.3 billion for the NIH (The Cancer Letter, May 2, 2025).
